1. Home
  2. SYRE vs VTMX Comparison

SYRE vs VTMX Comparison

Compare SYRE & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$43.49

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

VTMX

Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

HOLD

Current Price

$36.77

Market Cap

2.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYRE
VTMX
Founded
2013
1998
Country
United States
Mexico
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
SYRE
VTMX
Price
$43.49
$36.77
Analyst Decision
Strong Buy
Hold
Analyst Count
7
3
Target Price
$55.57
$30.50
AVG Volume (30 Days)
655.8K
69.3K
Earning Date
05-19-2026
01-01-0001
Dividend Yield
N/A
1.88%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$11.54
Revenue Next Year
N/A
$11.49
P/E Ratio
N/A
$47.91
Revenue Growth
N/A
N/A
52 Week Low
$10.91
$21.30
52 Week High
$45.76
$37.41

Technical Indicators

Market Signals
Indicator
SYRE
VTMX
Relative Strength Index (RSI) 71.28 76.28
Support Level $14.62 $30.07
Resistance Level N/A N/A
Average True Range (ATR) 2.29 1.08
MACD 0.74 0.34
Stochastic Oscillator 79.60 87.07

Price Performance

Historical Comparison
SYRE
VTMX

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: